BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

  November 7, 2025

   · 

  8 min read
• Press Releases

  Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF

  November 7, 2025

   · 

  4 min read
• Press Releases

  MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome

  November 7, 2025

   · 

  4 min read
• Press Releases

  Palatin Technologies Announces Pricing of Upsized $15.8 Million Public Offering

  November 7, 2025

   · 

  7 min read
• Press Releases

  Cronos Group Reports 2025 Third Quarter Results

  November 7, 2025

   · 

  53 min read
• Press Releases

  Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance

  November 7, 2025

   · 

  45 min read
• Press Releases

  Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

  November 7, 2025

   · 

  16 min read
• Press Releases

  Lilly’s selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight

  November 7, 2025

   · 

  7 min read
• Press Releases

  Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.

  November 7, 2025

   · 

  3 min read
• Press Releases

  Rezurock® now covered in Quebec for people living with chronic graft-versus-host disease (GVHD)

  November 7, 2025

   · 

  4 min read